Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
ClearOne Inc
CLRO
$15.2M
| $2.17M | ﹤0.01% |
11,194
+54
| +0.5% | +$10.1K |
|
2052
NetSol Technologies
NTWK
$49.3M
| $2.17M | ﹤0.01% |
279,402
+48,582
| +21% | +$291K |
|
2053
Hilltop Holdings
HTH
$2.25B
| $2.16M | ﹤0.01% |
112,584
-47,338
| -30% | -$987K |
|
|
TESO
2054
DELISTED
Tesco Corp
TESO
| $2.16M | ﹤0.01% |
298,716
+86,216
| +41% | +$674K |
|
|
NEWR
2055
DELISTED
New Relic, Inc.
NEWR
| $2.16M | ﹤0.01% |
59,300
-25,700
| -30% | -$963K |
|
|
EVOL
2056
DELISTED
Evolving Systems, Inc.
EVOL
| $2.16M | ﹤0.01% |
392,599
+21,300
| +6% | +$122K |
|
|
NNA
2057
DELISTED
Navios Maritime Acquisition Corporation
NNA
| $2.16M | ﹤0.01% |
47,780
+5,920
| +14% | +$307K |
|
2058
BK Technologies
BKTI
$292M
| $2.16M | ﹤0.01% |
109,440
+700
| +0.6% | +$14.6K |
|
2059
CVR Partners
UAN
$1.26B
| $2.15M | ﹤0.01% |
26,910
+14,020
| +109% | +$1.24M |
|
|
LEAF
2060
DELISTED
Leaf Group Ltd.
LEAF
| $2.15M | ﹤0.01% |
391,390
+77,590
| +25% | +$403K |
|
2061
Financial Institutions
FISI
$825M
| $2.15M | ﹤0.01% |
76,700
+16,300
| +27% | +$434K |
|
2062
inTEST
INTT
$179M
| $2.15M | ﹤0.01% |
507,900
+14,800
| +3% | +$57.9K |
|
|
TST
2063
DELISTED
TheStreet, Inc.
TST
| $2.15M | ﹤0.01% |
143,120
+4,060
| +3% | +$65.4K |
|
|
WPP
2064
DELISTED
WAUSAU PAPER CORP.
WPP
| $2.14M | ﹤0.01% |
209,400
+125,400
| +149% | +$1.23M |
|
2065
Nasdaq
NDAQ
$53.5B
| $2.14M | ﹤0.01% |
+110,400
| New | +$2.1M |
|
|
RNET
2066
DELISTED
RigNet, Inc.
RNET
| $2.14M | ﹤0.01% |
103,400
-25,200
| -20% | -$630K |
|
2067
LeMaitre Vascular
LMAT
$1.87B
| $2.14M | ﹤0.01% |
123,800
+6,900
| +6% | +$99.9K |
|
|
ENZY
2068
DELISTED
Enzymotec Ltd
ENZY
| $2.13M | ﹤0.01% |
217,700
+71,700
| +49% | +$679K |
|
2069
Koppers
KOP
$857M
| $2.12M | ﹤0.01% |
116,400
+67,300
| +137% | +$1.37M |
|
|
KSPN
2070
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
| $2.12M | ﹤0.01% |
29,660
+335
| +1% | +$24.9K |
|
|
COVS
2071
DELISTED
Covisint Corporation
COVS
| $2.12M | ﹤0.01% |
848,600
+39,600
| +5% | +$89.6K |
|
2072
Fortuna Silver Mines
FSM
$3.21B
| $2.12M | ﹤0.01% |
942,400
+97,400
| +12% | +$244K |
|
|
TSC
2073
DELISTED
TriState Capital Holdings, Inc.
TSC
| $2.12M | ﹤0.01% |
151,558
+43,558
| +40% | +$558K |
|
|
TGE
2074
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
| $2.12M | ﹤0.01% |
132,600
+96,800
| +270% | +$1.97M |
|
|
HGG
2075
DELISTED
hhgregg Inc.
HGG
| $2.12M | ﹤0.01% |
578,600
+76,800
| +15% | +$351K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.